SNDX (STOCKS)
Syndax Pharmaceuticals, Inc.
$21.720000
+0.400000 (+1.88%)
Prev close: $21.320000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael A. Metzger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,903.96M
- Employees
- 184
- P/E (TTM)
- -5.90
- P/B (TTM)
- 16.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.70 | $-0.73 | +0.0310 | +4.24% |
|
Jun 2025 (Q2)
|
$-0.83 | $-1.04 | +0.2064 | +19.92% |
|
Mar 2025 (Q1)
|
$-0.98 | $-1.36 | +0.3773 | +27.80% |
|
Dec 2024 (Q4)
|
$-1.10 | $-0.23 | -0.8663 | -370.69% |
Financial Statements
| Assets | $551.79M |
| Current Assets | $529.83M |
| Inventory | $25.00M |
| Other Current Assets | $504.83M |
| Noncurrent Assets | $21.96M |
| Fixed Assets | $128.00K |
| Other Non-current Assets | $21.83M |
| Liabilities | $436.36M |
| Current Liabilities | $114.19M |
| Accounts Payable | $13.83M |
| Wages | $15.64M |
| Other Current Liabilities | $84.72M |
| Noncurrent Liabilities | $322.18M |
| Equity | $115.43M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $115.43M |
| Liabilities And Equity | $551.79M |